Jennifer Proctor

1.7k total citations
32 papers, 272 citations indexed

About

Jennifer Proctor is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jennifer Proctor has authored 32 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Hematology and 9 papers in Oncology. Recurrent topics in Jennifer Proctor's work include Hematopoietic Stem Cell Transplantation (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jennifer Proctor is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jennifer Proctor collaborates with scholars based in United States and Canada. Jennifer Proctor's co-authors include Karen McGovern, Jeffery L. Kutok, Kerry White, Melissa Pink, Benjamin A. Alman, Lauren W. Wang, Sharon L. Hyzy, Suneel Apte, Puviindran Nadesan and Shabana Amanda Ali and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jennifer Proctor

32 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer Proctor United States	9	132	81	52	48	46	32	272
Hailong Tang China	10	107 0.8×	77 1.0×	28 0.5×	46 1.0×	36 0.8×	25	271
Bhumi Patel United States	7	150 1.1×	78 1.0×	80 1.5×	36 0.8×	36 0.8×	9	378
Mervat M. Khorshied Egypt	12	98 0.7×	44 0.5×	81 1.6×	62 1.3×	45 1.0×	46	342
Chisako Iriyama Japan	10	154 1.2×	81 1.0×	106 2.0×	55 1.1×	50 1.1×	17	329
Maho Ishikawa Japan	10	76 0.6×	53 0.7×	40 0.8×	88 1.8×	42 0.9×	40	277
Rafael Andrade Colombia	11	84 0.6×	88 1.1×	79 1.5×	39 0.8×	99 2.2×	28	297
Corina Schneidawind Germany	12	138 1.0×	84 1.0×	101 1.9×	25 0.5×	36 0.8×	25	302
Angela Maurer Germany	10	104 0.8×	56 0.7×	20 0.4×	46 1.0×	20 0.4×	23	271
Natallia Mikhalkevich United States	6	166 1.3×	39 0.5×	66 1.3×	33 0.7×	17 0.4×	8	283
Romain Aucagne France	9	205 1.6×	34 0.4×	58 1.1×	31 0.6×	23 0.5×	18	291

Countries citing papers authored by Jennifer Proctor

Since Specialization

Citations

This map shows the geographic impact of Jennifer Proctor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Proctor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Proctor more than expected).

Fields of papers citing papers by Jennifer Proctor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Proctor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Proctor. The network helps show where Jennifer Proctor may publish in the future.

Co-authorship network of co-authors of Jennifer Proctor

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Proctor. A scholar is included among the top collaborators of Jennifer Proctor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Proctor. Jennifer Proctor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saha, Asim, Sharon L. Hyzy, Nicholas C. Clark, et al.. (2022). A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice. Blood. 139(11). 1743–1759. 20 indexed citations

Proctor, Jennifer & Richard Marciano. (2021). An AI-Assisted Framework for Rapid Conversion of Descriptive Photo Metadata into Linked Data. 2021 IEEE International Conference on Big Data (Big Data). 2255–2261. 4 indexed citations

Pearse, Bradley R., Jennifer Proctor, Sean M. McDonough, et al.. (2020). A Non-Genotoxic Anti-CD117 Antibody Drug Conjugate (ADC) Designed for Patient Conditioning Prior to Stem Cell Transplant and HSC-Based Gene Therapy Has a Broad Therapeutic Window across Species. Biology of Blood and Marrow Transplantation. 26(3). S35–S36. 1 indexed citations

Lanieri, Leanne, Sean M. McDonough, Ganapathy N. Sarma, et al.. (2020). A Single Dose of a Novel Anti-Human CD117-Amanitin Antibody Drug Conjugate (ADC) Engineered for a Short Half-Life Provides Dual Conditioning and Anti-Leukemic Activity and Extends Survival Compared to Standard of Care in Multiple Preclinical Models of Acute Myeloid Leukemia (AML). Blood. 136(Supplement 1). 47–48. 5 indexed citations

Gillard, Geoffrey O., Jennifer Proctor, Sharon L. Hyzy, et al.. (2020). OP0307 A NOVEL TARGETED APPROACH TO ACHIEVE IMMUNE SYSTEM RESET: CD45-TARGETED ANTIBODY DRUG CONJUGATES AMELIORATE DISEASE IN PRECLINICAL AUTOIMMUNE DISEASE MODELS AND ENABLE AUTO-HSCT. Annals of the Rheumatic Diseases. 79. 190–191. 1 indexed citations

Dietz, Stephanie, et al.. (2019). Characteristics of animal-related motor vehicle crashes in select National Park Service units—United States, 1990–2013. Traffic Injury Prevention. 20(1). 58–63. 13 indexed citations

Proctor, Jennifer, Sharon L. Hyzy, Melissa Brooks, et al.. (2019). Single Doses of Antibody Drug Conjugates (ADCs) Targeted to CD117 or CD45 Have Potent In Vivo Anti-Leukemia Activity and Survival Benefit in Patient Derived AML Models. Biology of Blood and Marrow Transplantation. 25(3). S100–S101. 1 indexed citations

Kerrie, L., Kerry White, Jennifer Proctor, et al.. (2018). The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies. PLoS ONE. 13(8). e0200725–e0200725. 23 indexed citations

Hoban, Megan D., Ana Katherine Gonçalves, Jennifer Proctor, et al.. (2018). Aryl Hydrocarbon Receptor Antagonists Expand Adult Hematopoietic Stem Cells From Mobilized Peripheral Blood and Bone Marrow and Increase the Dose of CRISPR/Cas9 Gene-Edited NSG-Repopulating Cells. Biology of Blood and Marrow Transplantation. 24(3). S477–S477. 4 indexed citations

10.

Pearse, Bradley R., Sean M. McDonough, Jennifer Proctor, et al.. (2018). CD117-Amanitin Antibody Drug Conjugates Effectively Deplete Human and Non-Human Primate HSCs: Proof of Concept As a Targeted Strategy for Conditioning Patients for Bone Marrow Transplant. Blood. 132(Supplement 1). 3314–3314. 9 indexed citations

11.

Gonçalves, Ana Katherine, Megan D. Hoban, Jennifer Proctor, et al.. (2017). Phenotype Does Not Always Equal Function: HDAC Inhibitors and UM171, but Not SR1, Lead to Rapid Upregulation of CD90 on Non-Engrafting CD34+CD90-Negative Human Cells. Blood. 130(Suppl_1). 659–659. 1 indexed citations

12.

Henau, Olivier De, Taha Merghoub, David A. Winkler, et al.. (2016). Abstract 554: Checkpoint blockade therapy is improved by altering the immune suppressive microenvironment with IPI-549, a potent and selective inhibitor of PI3K-gamma, in preclinical models. Cancer Research. 76(14_Supplement). 554–554. 3 indexed citations

13.

Rausch, Matthew, Jeremy H. Tchaicha, Thomas T. Tibbitts, et al.. (2016). Abstract B032: The PI3K-γ inhibitor, IPI-549, increases antitumor immunity by targeting tumor-associated myeloid cells and remodeling the immune-suppressive tumor microenvironment. Cancer Immunology Research. 4(11_Supplement). B032–B032. 3 indexed citations

14.

White, Kerry, L. Kerrie, Jennifer Proctor, et al.. (2016). Abstract 376: Combination of duvelisib with either ibrutinib or dexamethasone prevents mTOR-dependent feedback in aggressive B-cell lymphoma cell lines. Cancer Research. 76(14_Supplement). 376–376. 5 indexed citations

15.

Nadesan, Puviindran, Shabana Amanda Ali, Heather Whetstone, et al.. (2014). Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth. Molecular Cancer Therapeutics. 13(5). 1259–1269. 59 indexed citations

16.

Tibbitts, Thomas T., Jennifer Proctor, James Conley, et al.. (2014). Impact of the Smoothened Inhibitor, IPI-926, on Smoothened Ciliary Localization and Hedgehog Pathway Activity. PLoS ONE. 9(3). e90534–e90534. 13 indexed citations

17.

Huang, Xiaoyan, Jennifer Proctor, Ya‐Ling Yang, et al.. (2013). The Potent PI3K-δ,γ Inhibitor, IPI-145, Exhibits Preclinical Activity In Murine and Human T-Cell Acute Lymphoblastic Leukemia. Blood. 122(21). 1438–1438. 3 indexed citations

18.

Thompson, Ryan C., et al.. (2013). The Potent PI3K-δ,γ Inhibitor IPI-145 Exhibits Differential Activity In Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines. Blood. 122(21). 1832–1832. 6 indexed citations

19.

McCann, Christopher, Whitfield B. Growdon, Michael D. Curley, et al.. (2011). Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model. PLoS ONE. 6(11). e28077–e28077. 57 indexed citations

20.

Lessard, Mark D., Jennifer Proctor, Beth Levy, et al.. (2006). Attenuation of murine lysosomal storage disease by allogeneic neonatal bone marrow transplantation using costimulatory blockade and donor lymphocyte infusion without myeloablation. Clinical Immunology. 119(2). 166–179. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact